Cyclerion Therapeutics SG&A Expense (Quarterly) Analysis

Cyclerion Therapeutics Inc (CYCN)

3.00 0.00 (0.00%) USD | NASDAQ | May 10, 16:00

3.00 0.00 (0.00%) After-Hours: 19:10

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2018. Upgrade now.

Date	Value
December 31, 2023	1.771M
September 30, 2023	2.131M
June 30, 2023	3.357M
March 31, 2023	3.269M
December 31, 2022	3.279M
September 30, 2022	3.104M
June 30, 2022	3.521M
March 31, 2022	3.952M
December 31, 2021	4.413M
September 30, 2021	4.601M
June 30, 2021	6.241M
March 31, 2021	5.365M

Date	Value
December 31, 2020	7.265M
September 30, 2020	8.033M
June 30, 2020	6.627M
March 31, 2020	6.891M
December 31, 2019	7.385M
September 30, 2019	7.119M
June 30, 2019	8.923M
March 31, 2019	10.98M
December 31, 2018	8.45M
September 30, 2018	7.787M
June 30, 2018	7.53M
March 31, 2018	3.769M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

1.771M

Minimum

Dec 2023

8.923M

Maximum

Jun 2019

5.118M

Average

4.601M

Median

Sep 2021

SG&A Expense (Quarterly) Benchmarks